We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Safety of Transplant Tissue Unaided by Lyophilization

By HospiMedica staff writers
Posted on 13 Apr 2004
Researchers have found that a method called lyophilization, used to inactivate retroviruses such as HIV from bones and connective tissues used in transplant procedures, is not effective.

In an experiment, investigators at the Laboratory for Comparative Orthopedic Research (LCOR) at Michigan State University (MSU, East Lansing, USA) put five samples each of bone and tissue infected with feline leukemia virus, similar to HIV, through the lyophilization process. More...
In every case, the virus survived the process.

"Contrary to currently held clinical beliefs, lyophilization should not be relied upon as an extra measure of security for processing connective tissue allografts,” said Steven P. Arnoczky, a professor of surgery in MSU's College of Veterinary Medicine and one of the lead researchers.

A study conducted in 1985 suggested that lyophilization, also known as freeze drying, might inactivate HIV. As a result, many surgeons seeking to protect their patients would specifically request tissues that had gone through the lyophilization process. In one case, distribution of tissues from an HIV-infected donor resulted in spreading the virus in 52 contaminated allografts. Still, the chance of contracting a bacterial or viral infection from a connective tissue implant is rare.




Related Links:
MSU

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.